A Uk Analysis of the Differential Drug Costs Per 1% Point Decrease in Hba1c Among Antihyperglycemic Agents That Inhibit Sglt2

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1287
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cytostatic Potential of Novel Agents That Inhibit the Regulation of Intracellular pH

British Journal of Cancer
Cancer ResearchOncology
2002English

Would the Per Se Illegal Treatment of Reverse Payment Settlements Inhibit Generic Drug Investment?

Journal of Competition Law and Economics
LawEconometricsEconomics
2012English

Novel Combinations of Agents Targeting Translation That Synergistically Inhibit Fungal Pathogens

Frontiers in Microbiology
Microbiology
2018English

Pnd94 - A Retrospective Database Analysis of Healthcare Resource Utilization and Associated Costs Among Patient Treated With Rufinamide in Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Correction To: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence Into Practice

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Magnitude and Pattern of Placebo Response in Clinical Trials of Oral Antihyperglycemic Agents: Data From the Food and Drug Administration 1999–2015

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Lipid-Lowering Agents That Cause Drug-Induced Hepatotoxicity

Clinics in Liver Disease
Hepatology
2007English

A Study on the Income Increase and Decrease Effect of Factors Causing Per Capita Income Differences Among Municipalities:

JOURNAL OF RURAL PLANNING ASSOCIATION
2018English

Synthesis of 2-Methyl-3-Indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 Without Gastric Damage

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy